|
1
|
Książkiewicz M, Markiewicz A and Zaczek
AJ: Epithelial-mesenchymal transition: a hallmark in metastasis
formation linking circulating tumor cells and cancer stem cells.
Pathobiology. 79:195–208. 2012. View Article : Google Scholar
|
|
2
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sánchez-Tilló E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balli D, Ustiyan V, Zhang Y, Wang IC,
Masino AJ, Ren X, Whitsett JA, Kalinichenko VV and Kalin TV: Foxm1
transcription factor is required for lung fibrosis and
epithelial-to-mesenchymal transition. EMBO J. 32:231–244. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Craene BD and Berx G: Regulatory networks
defining EMT during cancer initiation and progression. Nat Rev
Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wehbe M, Soudja SM, Mas A, Chasson L,
Guinamard R, de Tenbossche CP, Verdeil G, Van den Eynde B and
Schmitt-Verhulst AM: Epithelial-mesenchymal-transition-like and
TGFβ pathways associated with autochthonous inflammatory melanoma
development in mice. PLoS One. 7:e494192012. View Article : Google Scholar
|
|
7
|
Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS,
Hwang SG, An S, Yoon G, Gye MC, Yi JM, Kim MJ and Lee SJ: Claudin-1
induces epithelial-mesenchymal transition through activation of the
c-Abl-ERK signaling pathway in human liver cells. Oncogene.
32:4873–4882. 2013. View Article : Google Scholar
|
|
8
|
Tanaka Y, Terai Y, Kawaguchi H, Fujiwara
S, Yoo S, Tsunetoh S, Takai M, Kanemura M, Tanabe A and Ohmichi M:
Prognostic impact of EMT
(epithelial-mesenchymal-transition)-related protein expression in
endometrial cancer. Cancer Biol Ther. 14:13–19. 2013. View Article : Google Scholar :
|
|
9
|
Zheng X, Vittar NB, Gai X,
Fernandez-Barrena MG, Moser CD, Hu C, Almada LL, McCleary-Wheeler
AL, Elsawa SF, Vrabel AM, Shire AM, Comba A, Thorgeirsson SS, Kim
Y, Liu Q, Fernandez-Zapico ME and Roberts LR: The transcription
factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma
via a SNAI1-dependent mechanism. PLoS One. 7:e495812012. View Article : Google Scholar
|
|
10
|
Kim NH, Kim HS, Li XY, Lee I, Choi HS,
Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher
CA, Weiss SJ and Yook JI: A p53/miRNA-34 axis regulates
Snail1-dependent cancer cell epithelial-mesenchymal transition. J
Cell Biol. 195:417–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mathsyaraja H and Ostrowski MC: Setting
Snail2’s pace during EMT. Nat Cell Biol. 14:1122–1123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Smith BN and Odero-Marah VA: The role of
Snail in prostate cancer. Cell Adh Migr. 6:433–441. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimokawa M, Haraguchi M, Kobayashi W,
Higashi Y, Matsushita S, Kawai K, Kanekura T and Ozawa M: The
transcription factor Snail expressed in cutaneous squamous cell
carcinoma induces epithelial-mesenchymal transition and
down-regulates COX-2. Biochem Biophys Res Commun. 430:1078–1082.
2013. View Article : Google Scholar
|
|
14
|
Kume K, Haraguchi M, Hijioka H, Ishida T,
Miyawaki A, Nakamura N and Ozawa M: The transcription factor Snail
enhanced the degradation of E-cadherin and desmoglein 2 in oral
squamous cell carcinoma cells. Biochem Biophys Res Commun.
430:889–894. 2013. View Article : Google Scholar
|
|
15
|
Lemma S, Karihtala P, Haapasaari KM,
Jantunen E, Soini Y, Bloigu R, Pasanen AK, Turpeenniemi-Hujanen T
and Kuittinen O: Biological roles and prognostic values of the
epithelial-mesenchymal transition-mediating transcription factors
Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
Histopathology. 62:326–333. 2013. View Article : Google Scholar
|
|
16
|
Bhat-Nakshatri P, Appaiah H, Ballas C,
Pick-Franke P, Goulet R Jr, Badve S, Srour EF and Nakshatri H:
SLUG/SNAI2 and tumor necrosis factor generate breast cells with
CD44+/CD24− phenotype. BMC Cancer.
10:4112010. View Article : Google Scholar
|
|
17
|
Sun T, Sun BC, Zhao XL, Zhao N, Dong XY,
Che N, Yao Z, Ma YM, Gu Q, Zong WK and Liu ZY: Promotion of tumor
cell metastasis and vasculogenic mimicry by way of transcription
coactivation by Bcl-2 and Twist1: a study of hepatocellular
carcinoma. Hepatology. 54:1690–1706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Che N, Zhao XL, Sun T, Zhao XM, Gu Q, Dong
XY, Zhao N, Liu YR, Yao Z and Sun BC: The role of Twist1 in
hepatocellular carcinoma angiogenesis: a clinical study. Hum
Pathol. 42:840–847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu T, Sun B, Zhao X, Gu Q, Dong X, Yao Z,
Zhao N, Chi J, Liu N, Sun R and Ma Y: HER2/neu expression
correlates with vasculogenic mimicry in invasive breast carcinoma.
J Cell Mol Med. 17:116–122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu TJ, Sun BC, Zhao XL, Zhao XM, Sun T,
Gu Q, Yao Z, Dong XY, Zhao N and Liu N: CD133+ cells
with cancer stem cell characteristics associates with vasculogenic
mimicry in triple-negative breast cancer. Oncogene. 32:544–553.
2013. View Article : Google Scholar
|
|
21
|
Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q,
Dong X, Yao Z, Li R, Li J, Chi J and Sun R: Slug promoted
vasculogenic mimicry in hepatocellular carcinoma. J Cell Mol Med.
17:1038–1047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and Slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nassour M, Idoux-Gillet Y, Selmi A, Côme
C, Faraldo ML, Deugnier MA and Savagner P: Slug controls
stem/progenitor cell growth dynamics during mammary gland
morphogenesis. PLoS One. 7:e534982012. View Article : Google Scholar
|
|
24
|
Guo W, Keckesova Z, Donaher JL, Shibue T,
Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zürrer-Härdi U, Bell
G, Tam WL, Mani SA, van Oudenaarden A and Weinberg RA: Slug and
Sox9 cooperatively determine the mammary stem cell state. Cell.
148:1015–1028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shih JY and Yang PC: The EMT regulator
Slug and lung carcinogenesis. Carcinogenesis. 32:1299–1304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Basu-Roy U, Seo E, Ramanathapuram L, Rapp
TB, Perry JA, Orkin SH, Mansukhani A and Basilico C: Sox2 maintains
self renewal of tumor-initiating cells in osteosarcomas. Oncogene.
31:2270–2282. 2012. View Article : Google Scholar
|
|
27
|
Leis O, Eguiara A, Lopez-Arribillaga E,
Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R
and Martin AG: Sox2 expression in breast tumours and activation in
breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar
|
|
28
|
Ichida JK, Blanchard J, Lam K, Son EY,
Chung JE, Egli D, Loh KM, Carter AC, Di Giorgio FP, Koszka K,
Huangfu D, Akutsu H, Liu DR, Rubin LL and Eggan K: A small-molecule
inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by
inducing nanog. Cell Stem Cell. 5:491–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grad I, Hibaoui Y, Jaconi M, Chicha L,
Bergström-Tengzelius R, Sailani MR, Pelte MF, Dahoun S, Mitsiadis
TA, Töhönen V, Bouillaguet S, Antonarakis SE, Kere J, Zucchelli M,
Hovatta O and Feki A: NANOG priming before full reprogramming may
generate germ cell tumours. Eur Cell Mater. 22:258–274.
2011.PubMed/NCBI
|
